跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
S-104
首页
药物
S-104
S-104
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION APPARATUS
US 20260271474 A1
申请人: CANON KK
优先权: 2023
CN
EP
US
WO
4 件公开
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
US 2007224124 A1
申请人: UNIV SOUTH FLORIDA
优先权: 2007
US
WHITE PARTICLES FOR DISPLAY, PARTICLE DISPERSION FOR DISPLAY, DISPLAY MEDIUM AND DISPLAY DEVICE
US 2010225997 A1
申请人: FUJI XEROX CO LTD
优先权: 2009
US
Cystatin gene of monosomic addition line M14 of sugar beet
CN 101967487 A
申请人: UNIV HEILONGJIANG
优先权: 2010
CN
Skin care composition
US 11033480 B2
申请人: PROCTER & GAMBLE
优先权: 2017
US
Codonopsis pilosula polysaccharide COP-W1 and preparation method and application thereof
CN 107033255 A
申请人: UNIV ZUNYI MEDICAL
优先权: 2017
CN
Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and cancer drug including same
US 11377504 B2
申请人: NAT CANCER CENTER JAPAN
优先权: 2017
US
LAS1基因在皂苷高产型海参选育中的应用
CN 108642060 B
申请人: 中国海洋大学
优先权: 2018
CN
Selenophenol quinoline derivative as well as preparation method and application thereof
CN 112062758 A
申请人: GUANGZHOU XINMIN PEILIN MEDICINE TECH CO LTD
优先权: 2020
CN
B cell linear epitope of novel coronavirus S protein, antibody, identification method and application
CN 112194711 A
申请人: SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION SHENZHEN HEALTH INSPECTION CENTER SHENZHEN INST O
优先权: 2020
CN
第 1 / 2 页
上一页
下一页
药物
反馈